nodes	percent_of_prediction	percent_of_DWPC	metapath
Methotrexate—MTHFR—Alzheimer's disease	0.428	1	CbGaD
Methotrexate—SLC22A8—choroid plexus—Alzheimer's disease	0.0117	0.112	CbGeAlD
Methotrexate—ABCC11—embryo—Alzheimer's disease	0.00376	0.036	CbGeAlD
Methotrexate—MTHFR—blood vessel—Alzheimer's disease	0.00276	0.0264	CbGeAlD
Methotrexate—ATIC—embryo—Alzheimer's disease	0.00222	0.0212	CbGeAlD
Methotrexate—GGH—telencephalon—Alzheimer's disease	0.00212	0.0203	CbGeAlD
Methotrexate—ATIC—forebrain—Alzheimer's disease	0.00196	0.0188	CbGeAlD
Methotrexate—FOLR1—central nervous system—Alzheimer's disease	0.00181	0.0173	CbGeAlD
Methotrexate—ATIC—telencephalon—Alzheimer's disease	0.0018	0.0172	CbGeAlD
Methotrexate—FOLR1—cerebellum—Alzheimer's disease	0.00177	0.017	CbGeAlD
Methotrexate—SLC19A1—nervous system—Alzheimer's disease	0.00165	0.0158	CbGeAlD
Methotrexate—SLCO1C1—forebrain—Alzheimer's disease	0.00163	0.0156	CbGeAlD
Methotrexate—SLC19A1—central nervous system—Alzheimer's disease	0.00159	0.0152	CbGeAlD
Methotrexate—SLC19A1—cerebellum—Alzheimer's disease	0.00155	0.0149	CbGeAlD
Methotrexate—SLCO1C1—telencephalon—Alzheimer's disease	0.0015	0.0143	CbGeAlD
Methotrexate—DHFR—embryo—Alzheimer's disease	0.00149	0.0142	CbGeAlD
Methotrexate—MTHFR—forebrain—Alzheimer's disease	0.00146	0.0139	CbGeAlD
Methotrexate—FOLR1—brain—Alzheimer's disease	0.00144	0.0138	CbGeAlD
Methotrexate—MTHFR—telencephalon—Alzheimer's disease	0.00134	0.0128	CbGeAlD
Methotrexate—SLC46A1—nervous system—Alzheimer's disease	0.00127	0.0122	CbGeAlD
Methotrexate—PGD—forebrain—Alzheimer's disease	0.00127	0.0121	CbGeAlD
Methotrexate—SLC19A1—brain—Alzheimer's disease	0.00126	0.0121	CbGeAlD
Methotrexate—GGH—nervous system—Alzheimer's disease	0.00125	0.012	CbGeAlD
Methotrexate—SLC46A1—central nervous system—Alzheimer's disease	0.00123	0.0117	CbGeAlD
Methotrexate—TYMS—telencephalon—Alzheimer's disease	0.00122	0.0117	CbGeAlD
Methotrexate—DHFR—telencephalon—Alzheimer's disease	0.00121	0.0116	CbGeAlD
Methotrexate—GGH—central nervous system—Alzheimer's disease	0.00121	0.0115	CbGeAlD
Methotrexate—SLC46A1—cerebellum—Alzheimer's disease	0.0012	0.0115	CbGeAlD
Methotrexate—Folic Acid—MTHFR—Alzheimer's disease	0.00118	0.5	CrCbGaD
Methotrexate—Tetrahydrofolic acid—MTHFR—Alzheimer's disease	0.00118	0.5	CrCbGaD
Methotrexate—GGH—cerebellum—Alzheimer's disease	0.00118	0.0113	CbGeAlD
Methotrexate—PGD—telencephalon—Alzheimer's disease	0.00116	0.0111	CbGeAlD
Methotrexate—FPGS—nervous system—Alzheimer's disease	0.0011	0.0105	CbGeAlD
Methotrexate—SLC16A1—telencephalon—Alzheimer's disease	0.00109	0.0104	CbGeAlD
Methotrexate—ATIC—nervous system—Alzheimer's disease	0.00106	0.0102	CbGeAlD
Methotrexate—FPGS—central nervous system—Alzheimer's disease	0.00106	0.0101	CbGeAlD
Methotrexate—FPGS—cerebellum—Alzheimer's disease	0.00104	0.00991	CbGeAlD
Methotrexate—ATIC—central nervous system—Alzheimer's disease	0.00102	0.0098	CbGeAlD
Methotrexate—ATIC—cerebellum—Alzheimer's disease	0.001	0.00958	CbGeAlD
Methotrexate—ABCC10—telencephalon—Alzheimer's disease	0.000998	0.00955	CbGeAlD
Methotrexate—SLC46A1—brain—Alzheimer's disease	0.000973	0.0093	CbGeAlD
Methotrexate—GGH—brain—Alzheimer's disease	0.000957	0.00915	CbGeAlD
Methotrexate—SLCO1A2—forebrain—Alzheimer's disease	0.000936	0.00895	CbGeAlD
Methotrexate—ABCC4—forebrain—Alzheimer's disease	0.0009	0.00861	CbGeAlD
Methotrexate—SLCO1C1—nervous system—Alzheimer's disease	0.000885	0.00847	CbGeAlD
Methotrexate—SLCO1A2—telencephalon—Alzheimer's disease	0.00086	0.00823	CbGeAlD
Methotrexate—SLCO1C1—central nervous system—Alzheimer's disease	0.000852	0.00815	CbGeAlD
Methotrexate—FPGS—brain—Alzheimer's disease	0.000841	0.00805	CbGeAlD
Methotrexate—ATIC—brain—Alzheimer's disease	0.000814	0.00778	CbGeAlD
Methotrexate—MTHFR—nervous system—Alzheimer's disease	0.000791	0.00757	CbGeAlD
Methotrexate—SLCO3A1—nervous system—Alzheimer's disease	0.000779	0.00745	CbGeAlD
Methotrexate—MTHFR—central nervous system—Alzheimer's disease	0.000762	0.00729	CbGeAlD
Methotrexate—SLCO3A1—central nervous system—Alzheimer's disease	0.00075	0.00717	CbGeAlD
Methotrexate—MTHFR—cerebellum—Alzheimer's disease	0.000745	0.00712	CbGeAlD
Methotrexate—SLCO3A1—cerebellum—Alzheimer's disease	0.000733	0.00701	CbGeAlD
Methotrexate—TYMS—nervous system—Alzheimer's disease	0.000722	0.00691	CbGeAlD
Methotrexate—DHFR—nervous system—Alzheimer's disease	0.000715	0.00684	CbGeAlD
Methotrexate—ABCC1—telencephalon—Alzheimer's disease	0.000706	0.00675	CbGeAlD
Methotrexate—TYMS—central nervous system—Alzheimer's disease	0.000695	0.00665	CbGeAlD
Methotrexate—DHFR—central nervous system—Alzheimer's disease	0.000688	0.00658	CbGeAlD
Methotrexate—PGD—nervous system—Alzheimer's disease	0.000687	0.00657	CbGeAlD
Methotrexate—TYMS—cerebellum—Alzheimer's disease	0.000679	0.0065	CbGeAlD
Methotrexate—SLCO1C1—brain—Alzheimer's disease	0.000677	0.00647	CbGeAlD
Methotrexate—DHFR—cerebellum—Alzheimer's disease	0.000673	0.00643	CbGeAlD
Methotrexate—PGD—central nervous system—Alzheimer's disease	0.000662	0.00633	CbGeAlD
Methotrexate—PGD—cerebellum—Alzheimer's disease	0.000647	0.00619	CbGeAlD
Methotrexate—SLC16A1—nervous system—Alzheimer's disease	0.000642	0.00614	CbGeAlD
Methotrexate—SLC22A7—brain—Alzheimer's disease	0.000641	0.00613	CbGeAlD
Methotrexate—SLC22A6—brain—Alzheimer's disease	0.000619	0.00592	CbGeAlD
Methotrexate—SLC16A1—central nervous system—Alzheimer's disease	0.000618	0.00591	CbGeAlD
Methotrexate—MTHFR—brain—Alzheimer's disease	0.000605	0.00578	CbGeAlD
Methotrexate—SLC16A1—cerebellum—Alzheimer's disease	0.000604	0.00577	CbGeAlD
Methotrexate—SLCO3A1—brain—Alzheimer's disease	0.000595	0.00569	CbGeAlD
Methotrexate—ABCB1—blood vessel—Alzheimer's disease	0.000594	0.00568	CbGeAlD
Methotrexate—ABCC3—nervous system—Alzheimer's disease	0.000592	0.00566	CbGeAlD
Methotrexate—ABCG2—telencephalon—Alzheimer's disease	0.000584	0.00559	CbGeAlD
Methotrexate—ABCC3—central nervous system—Alzheimer's disease	0.00057	0.00545	CbGeAlD
Methotrexate—AOX1—cerebellum—Alzheimer's disease	0.00057	0.00545	CbGeAlD
Methotrexate—ABCC10—cerebellum—Alzheimer's disease	0.000555	0.0053	CbGeAlD
Methotrexate—TYMS—brain—Alzheimer's disease	0.000552	0.00528	CbGeAlD
Methotrexate—DHFR—brain—Alzheimer's disease	0.000546	0.00523	CbGeAlD
Methotrexate—PGD—brain—Alzheimer's disease	0.000525	0.00502	CbGeAlD
Methotrexate—SLCO1A2—nervous system—Alzheimer's disease	0.000508	0.00486	CbGeAlD
Methotrexate—SLC16A1—brain—Alzheimer's disease	0.00049	0.00469	CbGeAlD
Methotrexate—SLCO1A2—central nervous system—Alzheimer's disease	0.000489	0.00468	CbGeAlD
Methotrexate—ABCC4—nervous system—Alzheimer's disease	0.000489	0.00468	CbGeAlD
Methotrexate—SLC22A8—nervous system—Alzheimer's disease	0.000485	0.00464	CbGeAlD
Methotrexate—SLCO1A2—cerebellum—Alzheimer's disease	0.000478	0.00457	CbGeAlD
Methotrexate—ABCC4—central nervous system—Alzheimer's disease	0.000471	0.0045	CbGeAlD
Methotrexate—SLC22A8—central nervous system—Alzheimer's disease	0.000467	0.00447	CbGeAlD
Methotrexate—AOX1—brain—Alzheimer's disease	0.000463	0.00443	CbGeAlD
Methotrexate—ABCC3—brain—Alzheimer's disease	0.000453	0.00433	CbGeAlD
Methotrexate—ABCC10—brain—Alzheimer's disease	0.00045	0.00431	CbGeAlD
Methotrexate—Erectile dysfunction—Rivastigmine—Alzheimer's disease	0.000421	0.00155	CcSEcCtD
Methotrexate—Pneumonia—Memantine—Alzheimer's disease	0.000419	0.00154	CcSEcCtD
Methotrexate—Malaise—Galantamine—Alzheimer's disease	0.000418	0.00153	CcSEcCtD
Methotrexate—Photosensitivity reaction—Rivastigmine—Alzheimer's disease	0.000418	0.00153	CcSEcCtD
Methotrexate—Infestation—Memantine—Alzheimer's disease	0.000417	0.00153	CcSEcCtD
Methotrexate—Infestation NOS—Memantine—Alzheimer's disease	0.000417	0.00153	CcSEcCtD
Methotrexate—Vertigo—Galantamine—Alzheimer's disease	0.000416	0.00153	CcSEcCtD
Methotrexate—Depression—Memantine—Alzheimer's disease	0.000416	0.00153	CcSEcCtD
Methotrexate—Haemoglobin—Donepezil—Alzheimer's disease	0.000414	0.00152	CcSEcCtD
Methotrexate—Stevens-Johnson syndrome—Memantine—Alzheimer's disease	0.000413	0.00152	CcSEcCtD
Methotrexate—Hepatitis—Donepezil—Alzheimer's disease	0.000412	0.00151	CcSEcCtD
Methotrexate—Haemorrhage—Donepezil—Alzheimer's disease	0.000412	0.00151	CcSEcCtD
Methotrexate—Pneumonia—Rivastigmine—Alzheimer's disease	0.00041	0.00151	CcSEcCtD
Methotrexate—Renal failure—Memantine—Alzheimer's disease	0.00041	0.00151	CcSEcCtD
Methotrexate—Pharyngitis—Donepezil—Alzheimer's disease	0.000409	0.0015	CcSEcCtD
Methotrexate—Infestation—Rivastigmine—Alzheimer's disease	0.000408	0.0015	CcSEcCtD
Methotrexate—Infestation NOS—Rivastigmine—Alzheimer's disease	0.000408	0.0015	CcSEcCtD
Methotrexate—Drowsiness—Rivastigmine—Alzheimer's disease	0.000408	0.0015	CcSEcCtD
Methotrexate—Urinary tract disorder—Donepezil—Alzheimer's disease	0.000407	0.0015	CcSEcCtD
Methotrexate—Depression—Rivastigmine—Alzheimer's disease	0.000407	0.00149	CcSEcCtD
Methotrexate—Conjunctivitis—Memantine—Alzheimer's disease	0.000405	0.00149	CcSEcCtD
Methotrexate—Stevens-Johnson syndrome—Rivastigmine—Alzheimer's disease	0.000404	0.00149	CcSEcCtD
Methotrexate—Urethral disorder—Donepezil—Alzheimer's disease	0.000404	0.00149	CcSEcCtD
Methotrexate—Cough—Galantamine—Alzheimer's disease	0.000404	0.00148	CcSEcCtD
Methotrexate—Convulsion—Galantamine—Alzheimer's disease	0.000401	0.00147	CcSEcCtD
Methotrexate—Renal failure—Rivastigmine—Alzheimer's disease	0.000401	0.00147	CcSEcCtD
Methotrexate—Haematuria—Memantine—Alzheimer's disease	0.000398	0.00146	CcSEcCtD
Methotrexate—Visual impairment—Donepezil—Alzheimer's disease	0.000397	0.00146	CcSEcCtD
Methotrexate—Conjunctivitis—Rivastigmine—Alzheimer's disease	0.000397	0.00146	CcSEcCtD
Methotrexate—Hepatobiliary disease—Memantine—Alzheimer's disease	0.000394	0.00145	CcSEcCtD
Methotrexate—Myalgia—Galantamine—Alzheimer's disease	0.000394	0.00145	CcSEcCtD
Methotrexate—Chest pain—Galantamine—Alzheimer's disease	0.000394	0.00145	CcSEcCtD
Methotrexate—Arthralgia—Galantamine—Alzheimer's disease	0.000394	0.00145	CcSEcCtD
Methotrexate—Epistaxis—Memantine—Alzheimer's disease	0.000393	0.00145	CcSEcCtD
Methotrexate—ABCC1—cerebellum—Alzheimer's disease	0.000392	0.00375	CbGeAlD
Methotrexate—Unspecified disorder of skin and subcutaneous tissue—Galantamine—Alzheimer's disease	0.000392	0.00144	CcSEcCtD
Methotrexate—Sweating—Rivastigmine—Alzheimer's disease	0.000391	0.00144	CcSEcCtD
Methotrexate—Discomfort—Galantamine—Alzheimer's disease	0.00039	0.00143	CcSEcCtD
Methotrexate—Agranulocytosis—Memantine—Alzheimer's disease	0.000389	0.00143	CcSEcCtD
Methotrexate—Haematuria—Rivastigmine—Alzheimer's disease	0.000389	0.00143	CcSEcCtD
Methotrexate—SLCO1A2—brain—Alzheimer's disease	0.000388	0.00371	CbGeAlD
Methotrexate—ALB—brain—Alzheimer's disease	0.000386	0.00369	CbGeAlD
Methotrexate—Hepatobiliary disease—Rivastigmine—Alzheimer's disease	0.000386	0.00142	CcSEcCtD
Methotrexate—Epistaxis—Rivastigmine—Alzheimer's disease	0.000385	0.00141	CcSEcCtD
Methotrexate—Tinnitus—Donepezil—Alzheimer's disease	0.000384	0.00141	CcSEcCtD
Methotrexate—Confusional state—Galantamine—Alzheimer's disease	0.000381	0.0014	CcSEcCtD
Methotrexate—Haemoglobin—Memantine—Alzheimer's disease	0.000376	0.00138	CcSEcCtD
Methotrexate—Haemorrhage—Memantine—Alzheimer's disease	0.000374	0.00138	CcSEcCtD
Methotrexate—Hepatitis—Memantine—Alzheimer's disease	0.000374	0.00138	CcSEcCtD
Methotrexate—ABCC4—brain—Alzheimer's disease	0.000374	0.00357	CbGeAlD
Methotrexate—Pharyngitis—Memantine—Alzheimer's disease	0.000372	0.00137	CcSEcCtD
Methotrexate—SLC22A8—brain—Alzheimer's disease	0.000371	0.00355	CbGeAlD
Methotrexate—Nervous system disorder—Galantamine—Alzheimer's disease	0.000371	0.00136	CcSEcCtD
Methotrexate—Thrombocytopenia—Galantamine—Alzheimer's disease	0.00037	0.00136	CcSEcCtD
Methotrexate—Chills—Donepezil—Alzheimer's disease	0.00037	0.00136	CcSEcCtD
Methotrexate—Urinary tract disorder—Memantine—Alzheimer's disease	0.00037	0.00136	CcSEcCtD
Methotrexate—Haemoglobin—Rivastigmine—Alzheimer's disease	0.000368	0.00135	CcSEcCtD
Methotrexate—Skin disorder—Galantamine—Alzheimer's disease	0.000367	0.00135	CcSEcCtD
Methotrexate—Urethral disorder—Memantine—Alzheimer's disease	0.000367	0.00135	CcSEcCtD
Methotrexate—Haemorrhage—Rivastigmine—Alzheimer's disease	0.000366	0.00135	CcSEcCtD
Methotrexate—Hepatitis—Rivastigmine—Alzheimer's disease	0.000366	0.00135	CcSEcCtD
Methotrexate—Hyperhidrosis—Galantamine—Alzheimer's disease	0.000365	0.00134	CcSEcCtD
Methotrexate—Alopecia—Donepezil—Alzheimer's disease	0.000364	0.00134	CcSEcCtD
Methotrexate—Pharyngitis—Rivastigmine—Alzheimer's disease	0.000363	0.00134	CcSEcCtD
Methotrexate—Urinary tract disorder—Rivastigmine—Alzheimer's disease	0.000362	0.00133	CcSEcCtD
Methotrexate—Mental disorder—Donepezil—Alzheimer's disease	0.000361	0.00133	CcSEcCtD
Methotrexate—Visual impairment—Memantine—Alzheimer's disease	0.000361	0.00133	CcSEcCtD
Methotrexate—Anorexia—Galantamine—Alzheimer's disease	0.00036	0.00132	CcSEcCtD
Methotrexate—Urethral disorder—Rivastigmine—Alzheimer's disease	0.000359	0.00132	CcSEcCtD
Methotrexate—Malnutrition—Donepezil—Alzheimer's disease	0.000359	0.00132	CcSEcCtD
Methotrexate—Erythema—Donepezil—Alzheimer's disease	0.000359	0.00132	CcSEcCtD
Methotrexate—ABCB1—embryo—Alzheimer's disease	0.000354	0.00339	CbGeAlD
Methotrexate—Erythema multiforme—Memantine—Alzheimer's disease	0.000354	0.0013	CcSEcCtD
Methotrexate—Hypotension—Galantamine—Alzheimer's disease	0.000353	0.0013	CcSEcCtD
Methotrexate—Visual impairment—Rivastigmine—Alzheimer's disease	0.000353	0.0013	CcSEcCtD
Methotrexate—Dysgeusia—Donepezil—Alzheimer's disease	0.000351	0.00129	CcSEcCtD
Methotrexate—Eye disorder—Memantine—Alzheimer's disease	0.00035	0.00129	CcSEcCtD
Methotrexate—Tinnitus—Memantine—Alzheimer's disease	0.000349	0.00128	CcSEcCtD
Methotrexate—Cardiac disorder—Memantine—Alzheimer's disease	0.000347	0.00128	CcSEcCtD
Methotrexate—Back pain—Donepezil—Alzheimer's disease	0.000347	0.00128	CcSEcCtD
Methotrexate—Erythema multiforme—Rivastigmine—Alzheimer's disease	0.000346	0.00127	CcSEcCtD
Methotrexate—Musculoskeletal discomfort—Galantamine—Alzheimer's disease	0.000344	0.00127	CcSEcCtD
Methotrexate—Eye disorder—Rivastigmine—Alzheimer's disease	0.000342	0.00126	CcSEcCtD
Methotrexate—Insomnia—Galantamine—Alzheimer's disease	0.000342	0.00126	CcSEcCtD
Methotrexate—Tinnitus—Rivastigmine—Alzheimer's disease	0.000341	0.00125	CcSEcCtD
Methotrexate—Cardiac disorder—Rivastigmine—Alzheimer's disease	0.00034	0.00125	CcSEcCtD
Methotrexate—Angiopathy—Memantine—Alzheimer's disease	0.00034	0.00125	CcSEcCtD
Methotrexate—Paraesthesia—Galantamine—Alzheimer's disease	0.000339	0.00125	CcSEcCtD
Methotrexate—Vision blurred—Donepezil—Alzheimer's disease	0.000338	0.00124	CcSEcCtD
Methotrexate—Immune system disorder—Memantine—Alzheimer's disease	0.000338	0.00124	CcSEcCtD
Methotrexate—Mediastinal disorder—Memantine—Alzheimer's disease	0.000337	0.00124	CcSEcCtD
Methotrexate—Somnolence—Galantamine—Alzheimer's disease	0.000336	0.00123	CcSEcCtD
Methotrexate—Chills—Memantine—Alzheimer's disease	0.000336	0.00123	CcSEcCtD
Methotrexate—Ill-defined disorder—Donepezil—Alzheimer's disease	0.000333	0.00122	CcSEcCtD
Methotrexate—Dyspepsia—Galantamine—Alzheimer's disease	0.000333	0.00122	CcSEcCtD
Methotrexate—Angiopathy—Rivastigmine—Alzheimer's disease	0.000332	0.00122	CcSEcCtD
Methotrexate—Anaemia—Donepezil—Alzheimer's disease	0.000332	0.00122	CcSEcCtD
Methotrexate—Alopecia—Memantine—Alzheimer's disease	0.000331	0.00122	CcSEcCtD
Methotrexate—Mediastinal disorder—Rivastigmine—Alzheimer's disease	0.00033	0.00121	CcSEcCtD
Methotrexate—Chills—Rivastigmine—Alzheimer's disease	0.000329	0.00121	CcSEcCtD
Methotrexate—Decreased appetite—Galantamine—Alzheimer's disease	0.000329	0.00121	CcSEcCtD
Methotrexate—Mental disorder—Memantine—Alzheimer's disease	0.000328	0.00121	CcSEcCtD
Methotrexate—Gastrointestinal disorder—Galantamine—Alzheimer's disease	0.000326	0.0012	CcSEcCtD
Methotrexate—Malnutrition—Memantine—Alzheimer's disease	0.000326	0.0012	CcSEcCtD
Methotrexate—Fatigue—Galantamine—Alzheimer's disease	0.000326	0.0012	CcSEcCtD
Methotrexate—ABCG2—cerebellum—Alzheimer's disease	0.000325	0.00311	CbGeAlD
Methotrexate—Malaise—Donepezil—Alzheimer's disease	0.000324	0.00119	CcSEcCtD
Methotrexate—Alopecia—Rivastigmine—Alzheimer's disease	0.000324	0.00119	CcSEcCtD
Methotrexate—Vertigo—Donepezil—Alzheimer's disease	0.000322	0.00118	CcSEcCtD
Methotrexate—Mental disorder—Rivastigmine—Alzheimer's disease	0.000321	0.00118	CcSEcCtD
Methotrexate—Dysgeusia—Memantine—Alzheimer's disease	0.000319	0.00117	CcSEcCtD
Methotrexate—Malnutrition—Rivastigmine—Alzheimer's disease	0.000319	0.00117	CcSEcCtD
Methotrexate—Erythema—Rivastigmine—Alzheimer's disease	0.000319	0.00117	CcSEcCtD
Methotrexate—ABCC1—brain—Alzheimer's disease	0.000319	0.00305	CbGeAlD
Methotrexate—Back pain—Memantine—Alzheimer's disease	0.000315	0.00116	CcSEcCtD
Methotrexate—ABCB1—forebrain—Alzheimer's disease	0.000313	0.003	CbGeAlD
Methotrexate—Cough—Donepezil—Alzheimer's disease	0.000313	0.00115	CcSEcCtD
Methotrexate—Dysgeusia—Rivastigmine—Alzheimer's disease	0.000312	0.00115	CcSEcCtD
Methotrexate—Feeling abnormal—Galantamine—Alzheimer's disease	0.000311	0.00114	CcSEcCtD
Methotrexate—Convulsion—Donepezil—Alzheimer's disease	0.000311	0.00114	CcSEcCtD
Methotrexate—Gastrointestinal pain—Galantamine—Alzheimer's disease	0.000309	0.00114	CcSEcCtD
Methotrexate—Back pain—Rivastigmine—Alzheimer's disease	0.000308	0.00113	CcSEcCtD
Methotrexate—Vision blurred—Memantine—Alzheimer's disease	0.000307	0.00113	CcSEcCtD
Methotrexate—Arthralgia—Donepezil—Alzheimer's disease	0.000306	0.00112	CcSEcCtD
Methotrexate—Myalgia—Donepezil—Alzheimer's disease	0.000306	0.00112	CcSEcCtD
Methotrexate—Chest pain—Donepezil—Alzheimer's disease	0.000306	0.00112	CcSEcCtD
Methotrexate—Ill-defined disorder—Memantine—Alzheimer's disease	0.000302	0.00111	CcSEcCtD
Methotrexate—Discomfort—Donepezil—Alzheimer's disease	0.000302	0.00111	CcSEcCtD
Methotrexate—Anaemia—Memantine—Alzheimer's disease	0.000301	0.00111	CcSEcCtD
Methotrexate—Vision blurred—Rivastigmine—Alzheimer's disease	0.0003	0.0011	CcSEcCtD
Methotrexate—Abdominal pain—Galantamine—Alzheimer's disease	0.000299	0.0011	CcSEcCtD
Methotrexate—Body temperature increased—Galantamine—Alzheimer's disease	0.000299	0.0011	CcSEcCtD
Methotrexate—Ill-defined disorder—Rivastigmine—Alzheimer's disease	0.000296	0.00109	CcSEcCtD
Methotrexate—Confusional state—Donepezil—Alzheimer's disease	0.000295	0.00109	CcSEcCtD
Methotrexate—Anaemia—Rivastigmine—Alzheimer's disease	0.000295	0.00108	CcSEcCtD
Methotrexate—Malaise—Memantine—Alzheimer's disease	0.000294	0.00108	CcSEcCtD
Methotrexate—Vertigo—Memantine—Alzheimer's disease	0.000293	0.00108	CcSEcCtD
Methotrexate—Leukopenia—Memantine—Alzheimer's disease	0.000292	0.00107	CcSEcCtD
Methotrexate—Infection—Donepezil—Alzheimer's disease	0.000291	0.00107	CcSEcCtD
Methotrexate—ABCB1—telencephalon—Alzheimer's disease	0.000288	0.00276	CbGeAlD
Methotrexate—Malaise—Rivastigmine—Alzheimer's disease	0.000288	0.00106	CcSEcCtD
Methotrexate—Nervous system disorder—Donepezil—Alzheimer's disease	0.000287	0.00106	CcSEcCtD
Methotrexate—Thrombocytopenia—Donepezil—Alzheimer's disease	0.000287	0.00105	CcSEcCtD
Methotrexate—Vertigo—Rivastigmine—Alzheimer's disease	0.000286	0.00105	CcSEcCtD
Methotrexate—Cough—Memantine—Alzheimer's disease	0.000284	0.00104	CcSEcCtD
Methotrexate—Hyperhidrosis—Donepezil—Alzheimer's disease	0.000283	0.00104	CcSEcCtD
Methotrexate—Convulsion—Memantine—Alzheimer's disease	0.000282	0.00104	CcSEcCtD
Methotrexate—Anorexia—Donepezil—Alzheimer's disease	0.000279	0.00103	CcSEcCtD
Methotrexate—Hypersensitivity—Galantamine—Alzheimer's disease	0.000278	0.00102	CcSEcCtD
Methotrexate—Cough—Rivastigmine—Alzheimer's disease	0.000278	0.00102	CcSEcCtD
Methotrexate—Myalgia—Memantine—Alzheimer's disease	0.000277	0.00102	CcSEcCtD
Methotrexate—Arthralgia—Memantine—Alzheimer's disease	0.000277	0.00102	CcSEcCtD
Methotrexate—Chest pain—Memantine—Alzheimer's disease	0.000277	0.00102	CcSEcCtD
Methotrexate—Convulsion—Rivastigmine—Alzheimer's disease	0.000276	0.00101	CcSEcCtD
Methotrexate—Discomfort—Memantine—Alzheimer's disease	0.000274	0.00101	CcSEcCtD
Methotrexate—Hypotension—Donepezil—Alzheimer's disease	0.000274	0.00101	CcSEcCtD
Methotrexate—Chest pain—Rivastigmine—Alzheimer's disease	0.000271	0.000997	CcSEcCtD
Methotrexate—Arthralgia—Rivastigmine—Alzheimer's disease	0.000271	0.000997	CcSEcCtD
Methotrexate—Myalgia—Rivastigmine—Alzheimer's disease	0.000271	0.000997	CcSEcCtD
Methotrexate—Asthenia—Galantamine—Alzheimer's disease	0.000271	0.000996	CcSEcCtD
Methotrexate—Unspecified disorder of skin and subcutaneous tissue—Rivastigmine—Alzheimer's disease	0.00027	0.00099	CcSEcCtD
Methotrexate—Confusional state—Memantine—Alzheimer's disease	0.000268	0.000985	CcSEcCtD
Methotrexate—Discomfort—Rivastigmine—Alzheimer's disease	0.000268	0.000985	CcSEcCtD
Methotrexate—Musculoskeletal discomfort—Donepezil—Alzheimer's disease	0.000267	0.000981	CcSEcCtD
Methotrexate—Insomnia—Donepezil—Alzheimer's disease	0.000265	0.000973	CcSEcCtD
Methotrexate—Infection—Memantine—Alzheimer's disease	0.000264	0.000971	CcSEcCtD
Methotrexate—ABCG2—brain—Alzheimer's disease	0.000264	0.00252	CbGeAlD
Methotrexate—Paraesthesia—Donepezil—Alzheimer's disease	0.000263	0.000966	CcSEcCtD
Methotrexate—Confusional state—Rivastigmine—Alzheimer's disease	0.000262	0.000964	CcSEcCtD
Methotrexate—Dyspnoea—Donepezil—Alzheimer's disease	0.000261	0.00096	CcSEcCtD
Methotrexate—Nervous system disorder—Memantine—Alzheimer's disease	0.000261	0.000958	CcSEcCtD
Methotrexate—Somnolence—Donepezil—Alzheimer's disease	0.00026	0.000957	CcSEcCtD
Methotrexate—Thrombocytopenia—Memantine—Alzheimer's disease	0.00026	0.000957	CcSEcCtD
Methotrexate—Diarrhoea—Galantamine—Alzheimer's disease	0.000259	0.00095	CcSEcCtD
Methotrexate—Infection—Rivastigmine—Alzheimer's disease	0.000258	0.00095	CcSEcCtD
Methotrexate—Skin disorder—Memantine—Alzheimer's disease	0.000258	0.000949	CcSEcCtD
Methotrexate—Dyspepsia—Donepezil—Alzheimer's disease	0.000258	0.000947	CcSEcCtD
Methotrexate—Hyperhidrosis—Memantine—Alzheimer's disease	0.000257	0.000945	CcSEcCtD
Methotrexate—Nervous system disorder—Rivastigmine—Alzheimer's disease	0.000255	0.000938	CcSEcCtD
Methotrexate—Thrombocytopenia—Rivastigmine—Alzheimer's disease	0.000255	0.000936	CcSEcCtD
Methotrexate—Decreased appetite—Donepezil—Alzheimer's disease	0.000255	0.000936	CcSEcCtD
Methotrexate—Anorexia—Memantine—Alzheimer's disease	0.000254	0.000932	CcSEcCtD
Methotrexate—Gastrointestinal disorder—Donepezil—Alzheimer's disease	0.000253	0.000929	CcSEcCtD
Methotrexate—Skin disorder—Rivastigmine—Alzheimer's disease	0.000253	0.000929	CcSEcCtD
Methotrexate—Fatigue—Donepezil—Alzheimer's disease	0.000253	0.000928	CcSEcCtD
Methotrexate—Hyperhidrosis—Rivastigmine—Alzheimer's disease	0.000252	0.000924	CcSEcCtD
Methotrexate—Pain—Donepezil—Alzheimer's disease	0.00025	0.00092	CcSEcCtD
Methotrexate—Dizziness—Galantamine—Alzheimer's disease	0.00025	0.000918	CcSEcCtD
Methotrexate—Hypotension—Memantine—Alzheimer's disease	0.000249	0.000913	CcSEcCtD
Methotrexate—Anorexia—Rivastigmine—Alzheimer's disease	0.000248	0.000911	CcSEcCtD
Methotrexate—Hypotension—Rivastigmine—Alzheimer's disease	0.000243	0.000893	CcSEcCtD
Methotrexate—Musculoskeletal discomfort—Memantine—Alzheimer's disease	0.000242	0.00089	CcSEcCtD
Methotrexate—Feeling abnormal—Donepezil—Alzheimer's disease	0.000241	0.000887	CcSEcCtD
Methotrexate—Insomnia—Memantine—Alzheimer's disease	0.000241	0.000884	CcSEcCtD
Methotrexate—Vomiting—Galantamine—Alzheimer's disease	0.00024	0.000883	CcSEcCtD
Methotrexate—Gastrointestinal pain—Donepezil—Alzheimer's disease	0.00024	0.00088	CcSEcCtD
Methotrexate—Paraesthesia—Memantine—Alzheimer's disease	0.000239	0.000878	CcSEcCtD
Methotrexate—Rash—Galantamine—Alzheimer's disease	0.000238	0.000876	CcSEcCtD
Methotrexate—Dermatitis—Galantamine—Alzheimer's disease	0.000238	0.000875	CcSEcCtD
Methotrexate—Dyspnoea—Memantine—Alzheimer's disease	0.000237	0.000871	CcSEcCtD
Methotrexate—Musculoskeletal discomfort—Rivastigmine—Alzheimer's disease	0.000237	0.000871	CcSEcCtD
Methotrexate—Headache—Galantamine—Alzheimer's disease	0.000237	0.00087	CcSEcCtD
Methotrexate—Somnolence—Memantine—Alzheimer's disease	0.000236	0.000869	CcSEcCtD
Methotrexate—Insomnia—Rivastigmine—Alzheimer's disease	0.000235	0.000865	CcSEcCtD
Methotrexate—Dyspepsia—Memantine—Alzheimer's disease	0.000234	0.00086	CcSEcCtD
Methotrexate—Paraesthesia—Rivastigmine—Alzheimer's disease	0.000234	0.000858	CcSEcCtD
Methotrexate—Urticaria—Donepezil—Alzheimer's disease	0.000233	0.000855	CcSEcCtD
Methotrexate—Dyspnoea—Rivastigmine—Alzheimer's disease	0.000232	0.000852	CcSEcCtD
Methotrexate—Abdominal pain—Donepezil—Alzheimer's disease	0.000232	0.000851	CcSEcCtD
Methotrexate—Body temperature increased—Donepezil—Alzheimer's disease	0.000232	0.000851	CcSEcCtD
Methotrexate—Somnolence—Rivastigmine—Alzheimer's disease	0.000231	0.00085	CcSEcCtD
Methotrexate—Decreased appetite—Memantine—Alzheimer's disease	0.000231	0.00085	CcSEcCtD
Methotrexate—Gastrointestinal disorder—Memantine—Alzheimer's disease	0.00023	0.000844	CcSEcCtD
Methotrexate—Fatigue—Memantine—Alzheimer's disease	0.000229	0.000843	CcSEcCtD
Methotrexate—Dyspepsia—Rivastigmine—Alzheimer's disease	0.000229	0.000842	CcSEcCtD
Methotrexate—Pain—Memantine—Alzheimer's disease	0.000227	0.000836	CcSEcCtD
Methotrexate—Decreased appetite—Rivastigmine—Alzheimer's disease	0.000226	0.000831	CcSEcCtD
Methotrexate—Gastrointestinal disorder—Rivastigmine—Alzheimer's disease	0.000225	0.000825	CcSEcCtD
Methotrexate—Nausea—Galantamine—Alzheimer's disease	0.000225	0.000825	CcSEcCtD
Methotrexate—Fatigue—Rivastigmine—Alzheimer's disease	0.000224	0.000824	CcSEcCtD
Methotrexate—Pain—Rivastigmine—Alzheimer's disease	0.000223	0.000818	CcSEcCtD
Methotrexate—Feeling abnormal—Memantine—Alzheimer's disease	0.000219	0.000805	CcSEcCtD
Methotrexate—Gastrointestinal pain—Memantine—Alzheimer's disease	0.000217	0.000799	CcSEcCtD
Methotrexate—Hypersensitivity—Donepezil—Alzheimer's disease	0.000216	0.000793	CcSEcCtD
Methotrexate—Feeling abnormal—Rivastigmine—Alzheimer's disease	0.000214	0.000788	CcSEcCtD
Methotrexate—Gastrointestinal pain—Rivastigmine—Alzheimer's disease	0.000213	0.000782	CcSEcCtD
Methotrexate—Urticaria—Memantine—Alzheimer's disease	0.000211	0.000776	CcSEcCtD
Methotrexate—Body temperature increased—Memantine—Alzheimer's disease	0.00021	0.000773	CcSEcCtD
Methotrexate—Abdominal pain—Memantine—Alzheimer's disease	0.00021	0.000773	CcSEcCtD
Methotrexate—Asthenia—Donepezil—Alzheimer's disease	0.00021	0.000772	CcSEcCtD
Methotrexate—Pruritus—Donepezil—Alzheimer's disease	0.000207	0.000761	CcSEcCtD
Methotrexate—Urticaria—Rivastigmine—Alzheimer's disease	0.000207	0.000759	CcSEcCtD
Methotrexate—Abdominal pain—Rivastigmine—Alzheimer's disease	0.000206	0.000756	CcSEcCtD
Methotrexate—Body temperature increased—Rivastigmine—Alzheimer's disease	0.000206	0.000756	CcSEcCtD
Methotrexate—Diarrhoea—Donepezil—Alzheimer's disease	0.0002	0.000736	CcSEcCtD
Methotrexate—Hypersensitivity—Memantine—Alzheimer's disease	0.000196	0.00072	CcSEcCtD
Methotrexate—Dizziness—Donepezil—Alzheimer's disease	0.000194	0.000712	CcSEcCtD
Methotrexate—Hypersensitivity—Rivastigmine—Alzheimer's disease	0.000192	0.000704	CcSEcCtD
Methotrexate—Asthenia—Memantine—Alzheimer's disease	0.000191	0.000701	CcSEcCtD
Methotrexate—Pruritus—Memantine—Alzheimer's disease	0.000188	0.000691	CcSEcCtD
Methotrexate—Asthenia—Rivastigmine—Alzheimer's disease	0.000187	0.000686	CcSEcCtD
Methotrexate—Vomiting—Donepezil—Alzheimer's disease	0.000186	0.000684	CcSEcCtD
Methotrexate—Rash—Donepezil—Alzheimer's disease	0.000185	0.000679	CcSEcCtD
Methotrexate—Dermatitis—Donepezil—Alzheimer's disease	0.000185	0.000678	CcSEcCtD
Methotrexate—Pruritus—Rivastigmine—Alzheimer's disease	0.000184	0.000676	CcSEcCtD
Methotrexate—Headache—Donepezil—Alzheimer's disease	0.000184	0.000674	CcSEcCtD
Methotrexate—Diarrhoea—Memantine—Alzheimer's disease	0.000182	0.000669	CcSEcCtD
Methotrexate—Diarrhoea—Rivastigmine—Alzheimer's disease	0.000178	0.000654	CcSEcCtD
Methotrexate—Dizziness—Memantine—Alzheimer's disease	0.000176	0.000646	CcSEcCtD
Methotrexate—Nausea—Donepezil—Alzheimer's disease	0.000174	0.000639	CcSEcCtD
Methotrexate—Dizziness—Rivastigmine—Alzheimer's disease	0.000172	0.000632	CcSEcCtD
Methotrexate—ABCB1—nervous system—Alzheimer's disease	0.00017	0.00163	CbGeAlD
Methotrexate—Vomiting—Memantine—Alzheimer's disease	0.000169	0.000621	CcSEcCtD
Methotrexate—Rash—Memantine—Alzheimer's disease	0.000168	0.000616	CcSEcCtD
Methotrexate—Dermatitis—Memantine—Alzheimer's disease	0.000168	0.000616	CcSEcCtD
Methotrexate—Headache—Memantine—Alzheimer's disease	0.000167	0.000612	CcSEcCtD
Methotrexate—Vomiting—Rivastigmine—Alzheimer's disease	0.000165	0.000608	CcSEcCtD
Methotrexate—Rash—Rivastigmine—Alzheimer's disease	0.000164	0.000603	CcSEcCtD
Methotrexate—Dermatitis—Rivastigmine—Alzheimer's disease	0.000164	0.000602	CcSEcCtD
Methotrexate—ABCB1—central nervous system—Alzheimer's disease	0.000164	0.00157	CbGeAlD
Methotrexate—Headache—Rivastigmine—Alzheimer's disease	0.000163	0.000599	CcSEcCtD
Methotrexate—ABCB1—cerebellum—Alzheimer's disease	0.00016	0.00153	CbGeAlD
Methotrexate—Nausea—Memantine—Alzheimer's disease	0.000158	0.00058	CcSEcCtD
Methotrexate—Nausea—Rivastigmine—Alzheimer's disease	0.000155	0.000568	CcSEcCtD
Methotrexate—ABCB1—brain—Alzheimer's disease	0.00013	0.00124	CbGeAlD
Methotrexate—SLC19A1—Metabolism—AKT1—Alzheimer's disease	1.15e-05	5.96e-05	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	1.15e-05	5.95e-05	CbGpPWpGaD
Methotrexate—ABCC1—Disease—ADAM10—Alzheimer's disease	1.14e-05	5.94e-05	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—ENO1—Alzheimer's disease	1.14e-05	5.91e-05	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—PTGS1—Alzheimer's disease	1.14e-05	5.91e-05	CbGpPWpGaD
Methotrexate—MTHFR—Metabolism—INS—Alzheimer's disease	1.14e-05	5.91e-05	CbGpPWpGaD
Methotrexate—AOX1—Metabolism—PPARG—Alzheimer's disease	1.13e-05	5.88e-05	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—ABCA1—Alzheimer's disease	1.13e-05	5.88e-05	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism—LPL—Alzheimer's disease	1.13e-05	5.87e-05	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—ACHE—Alzheimer's disease	1.12e-05	5.84e-05	CbGpPWpGaD
Methotrexate—DHFR—Cell Cycle—TP53—Alzheimer's disease	1.12e-05	5.83e-05	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—PPARGC1A—Alzheimer's disease	1.12e-05	5.82e-05	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—CYP2D6—Alzheimer's disease	1.12e-05	5.8e-05	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—HMOX1—Alzheimer's disease	1.12e-05	5.79e-05	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—BCHE—Alzheimer's disease	1.11e-05	5.78e-05	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—INPP5D—Alzheimer's disease	1.11e-05	5.77e-05	CbGpPWpGaD
Methotrexate—AOX1—Metabolism—INS—Alzheimer's disease	1.11e-05	5.77e-05	CbGpPWpGaD
Methotrexate—TYMS—Metabolism—MTHFR—Alzheimer's disease	1.11e-05	5.76e-05	CbGpPWpGaD
Methotrexate—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—Alzheimer's disease	1.09e-05	5.66e-05	CbGpPWpGaD
Methotrexate—MTHFR—Disease—PTGS2—Alzheimer's disease	1.09e-05	5.66e-05	CbGpPWpGaD
Methotrexate—SLC16A1—Hemostasis—TP53—Alzheimer's disease	1.08e-05	5.63e-05	CbGpPWpGaD
Methotrexate—SLC16A1—Metabolism—CALM1—Alzheimer's disease	1.08e-05	5.62e-05	CbGpPWpGaD
Methotrexate—SLC16A1—Metabolism—APOE—Alzheimer's disease	1.08e-05	5.6e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism of lipids and lipoproteins—PPARGC1A—Alzheimer's disease	1.07e-05	5.56e-05	CbGpPWpGaD
Methotrexate—ABCC4—Hemostasis—VEGFA—Alzheimer's disease	1.07e-05	5.56e-05	CbGpPWpGaD
Methotrexate—SLC16A1—Metabolism—CAV1—Alzheimer's disease	1.07e-05	5.55e-05	CbGpPWpGaD
Methotrexate—AOX1—Disease—PTGS2—Alzheimer's disease	1.06e-05	5.53e-05	CbGpPWpGaD
Methotrexate—DHFR—Disease—NOS3—Alzheimer's disease	1.06e-05	5.5e-05	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—BCHE—Alzheimer's disease	1.06e-05	5.49e-05	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—PTGS1—Alzheimer's disease	1.05e-05	5.47e-05	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—ENO1—Alzheimer's disease	1.05e-05	5.47e-05	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—PLCB1—Alzheimer's disease	1.05e-05	5.46e-05	CbGpPWpGaD
Methotrexate—ALB—Hemostasis—PRKCG—Alzheimer's disease	1.04e-05	5.4e-05	CbGpPWpGaD
Methotrexate—TYMS—Metabolism—CALM1—Alzheimer's disease	1.04e-05	5.38e-05	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—CYP2D6—Alzheimer's disease	1.03e-05	5.37e-05	CbGpPWpGaD
Methotrexate—TYMS—Metabolism—APOE—Alzheimer's disease	1.03e-05	5.36e-05	CbGpPWpGaD
Methotrexate—DHFR—Metabolism—PPARG—Alzheimer's disease	1.03e-05	5.35e-05	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	1.03e-05	5.35e-05	CbGpPWpGaD
Methotrexate—TYMS—Metabolism—CAV1—Alzheimer's disease	1.02e-05	5.31e-05	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—LPL—Alzheimer's disease	1.02e-05	5.3e-05	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—ABCA1—Alzheimer's disease	1.02e-05	5.29e-05	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism—MTHFR—Alzheimer's disease	1.02e-05	5.28e-05	CbGpPWpGaD
Methotrexate—ALB—Transmembrane transport of small molecules—HMOX1—Alzheimer's disease	1.01e-05	5.26e-05	CbGpPWpGaD
Methotrexate—DHFR—Metabolism—INS—Alzheimer's disease	1.01e-05	5.25e-05	CbGpPWpGaD
Methotrexate—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—Alzheimer's disease	1e-05	5.2e-05	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—PLCB1—Alzheimer's disease	9.98e-06	5.18e-05	CbGpPWpGaD
Methotrexate—MTHFR—Metabolism—NOS3—Alzheimer's disease	9.98e-06	5.18e-05	CbGpPWpGaD
Methotrexate—SLC46A1—Disease—IL6—Alzheimer's disease	9.84e-06	5.11e-05	CbGpPWpGaD
Methotrexate—ABCC4—Hemostasis—TGFB1—Alzheimer's disease	9.82e-06	5.1e-05	CbGpPWpGaD
Methotrexate—TYMS—Cell Cycle—TP53—Alzheimer's disease	9.8e-06	5.09e-05	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—BCHE—Alzheimer's disease	9.8e-06	5.09e-05	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	9.79e-06	5.09e-05	CbGpPWpGaD
Methotrexate—FPGS—Metabolism—AKT1—Alzheimer's disease	9.76e-06	5.07e-05	CbGpPWpGaD
Methotrexate—ATIC—Metabolism—AKT1—Alzheimer's disease	9.76e-06	5.07e-05	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—PPARGC1A—Alzheimer's disease	9.75e-06	5.06e-05	CbGpPWpGaD
Methotrexate—AOX1—Metabolism—NOS3—Alzheimer's disease	9.75e-06	5.06e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism of lipids and lipoproteins—LPL—Alzheimer's disease	9.74e-06	5.06e-05	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—HMOX1—Alzheimer's disease	9.71e-06	5.04e-05	CbGpPWpGaD
Methotrexate—DHFR—Disease—PTGS2—Alzheimer's disease	9.68e-06	5.03e-05	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—ABCA1—Alzheimer's disease	9.68e-06	5.03e-05	CbGpPWpGaD
Methotrexate—ABCC1—Disease—LPL—Alzheimer's disease	9.54e-06	4.95e-05	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism—CALM1—Alzheimer's disease	9.51e-06	4.94e-05	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism—APOE—Alzheimer's disease	9.47e-06	4.92e-05	CbGpPWpGaD
Methotrexate—ALB—Platelet activation, signaling and aggregation—VEGFA—Alzheimer's disease	9.39e-06	4.88e-05	CbGpPWpGaD
Methotrexate—SLC16A1—Metabolism—PPARG—Alzheimer's disease	9.39e-06	4.88e-05	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism—CAV1—Alzheimer's disease	9.39e-06	4.87e-05	CbGpPWpGaD
Methotrexate—ABCC1—Disease—PRKCG—Alzheimer's disease	9.28e-06	4.82e-05	CbGpPWpGaD
Methotrexate—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—Alzheimer's disease	9.25e-06	4.8e-05	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—PLCB1—Alzheimer's disease	9.25e-06	4.8e-05	CbGpPWpGaD
Methotrexate—SLC16A1—Metabolism—INS—Alzheimer's disease	9.21e-06	4.78e-05	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—MTHFR—Alzheimer's disease	9.18e-06	4.77e-05	CbGpPWpGaD
Methotrexate—SLC16A1—Hemostasis—AKT1—Alzheimer's disease	9.16e-06	4.75e-05	CbGpPWpGaD
Methotrexate—MTHFR—Metabolism—PTGS2—Alzheimer's disease	9.13e-06	4.74e-05	CbGpPWpGaD
Methotrexate—ALB—Hemostasis—PLAU—Alzheimer's disease	9.1e-06	4.72e-05	CbGpPWpGaD
Methotrexate—SLC46A1—Disease—AKT1—Alzheimer's disease	9.08e-06	4.71e-05	CbGpPWpGaD
Methotrexate—ALB—Hemostasis—CALM1—Alzheimer's disease	9e-06	4.67e-05	CbGpPWpGaD
Methotrexate—PGD—Disease—IL6—Alzheimer's disease	9e-06	4.67e-05	CbGpPWpGaD
Methotrexate—TYMS—Metabolism—PPARG—Alzheimer's disease	9e-06	4.67e-05	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—ABCA1—Alzheimer's disease	8.96e-06	4.65e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—TPI1—Alzheimer's disease	8.95e-06	4.65e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—CHAT—Alzheimer's disease	8.95e-06	4.65e-05	CbGpPWpGaD
Methotrexate—AOX1—Metabolism—PTGS2—Alzheimer's disease	8.91e-06	4.63e-05	CbGpPWpGaD
Methotrexate—ALB—Hemostasis—CAV1—Alzheimer's disease	8.89e-06	4.61e-05	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—LPL—Alzheimer's disease	8.88e-06	4.61e-05	CbGpPWpGaD
Methotrexate—ABCB1—Transmembrane transport of small molecules—HMOX1—Alzheimer's disease	8.88e-06	4.61e-05	CbGpPWpGaD
Methotrexate—DHFR—Metabolism—NOS3—Alzheimer's disease	8.87e-06	4.6e-05	CbGpPWpGaD
Methotrexate—TYMS—Metabolism—INS—Alzheimer's disease	8.82e-06	4.58e-05	CbGpPWpGaD
Methotrexate—ABCC1—Disease—CCR5—Alzheimer's disease	8.79e-06	4.56e-05	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—PPARGC1A—Alzheimer's disease	8.78e-06	4.56e-05	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—HMOX1—Alzheimer's disease	8.74e-06	4.54e-05	CbGpPWpGaD
Methotrexate—ALB—Platelet activation, signaling and aggregation—TGFB1—Alzheimer's disease	8.62e-06	4.48e-05	CbGpPWpGaD
Methotrexate—ABCC1—Disease—MTHFR—Alzheimer's disease	8.59e-06	4.46e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—MAOB—Alzheimer's disease	8.58e-06	4.46e-05	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—CALM1—Alzheimer's disease	8.58e-06	4.45e-05	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—APOE—Alzheimer's disease	8.55e-06	4.44e-05	CbGpPWpGaD
Methotrexate—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—Alzheimer's disease	8.49e-06	4.41e-05	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—CAV1—Alzheimer's disease	8.47e-06	4.4e-05	CbGpPWpGaD
Methotrexate—ALB—Hemostasis—F2—Alzheimer's disease	8.46e-06	4.39e-05	CbGpPWpGaD
Methotrexate—ALB—Hemostasis—NOS2—Alzheimer's disease	8.36e-06	4.34e-05	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—PPARGC1A—Alzheimer's disease	8.34e-06	4.33e-05	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—HMOX1—Alzheimer's disease	8.3e-06	4.31e-05	CbGpPWpGaD
Methotrexate—PGD—Disease—AKT1—Alzheimer's disease	8.3e-06	4.31e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—GAPDH—Alzheimer's disease	8.26e-06	4.29e-05	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism—PPARG—Alzheimer's disease	8.25e-06	4.28e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	8.17e-06	4.24e-05	CbGpPWpGaD
Methotrexate—DHFR—Metabolism—PTGS2—Alzheimer's disease	8.11e-06	4.21e-05	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism—INS—Alzheimer's disease	8.09e-06	4.2e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	8.09e-06	4.2e-05	CbGpPWpGaD
Methotrexate—ABCC4—Hemostasis—TP53—Alzheimer's disease	8.09e-06	4.2e-05	CbGpPWpGaD
Methotrexate—SLC16A1—Metabolism—NOS3—Alzheimer's disease	8.08e-06	4.19e-05	CbGpPWpGaD
Methotrexate—ABCC1—Disease—CALM1—Alzheimer's disease	8.03e-06	4.17e-05	CbGpPWpGaD
Methotrexate—ABCC1—Disease—APOE—Alzheimer's disease	8e-06	4.15e-05	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—MTHFR—Alzheimer's disease	8e-06	4.15e-05	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—LPL—Alzheimer's disease	7.99e-06	4.15e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—A2M—Alzheimer's disease	7.98e-06	4.14e-05	CbGpPWpGaD
Methotrexate—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—Alzheimer's disease	7.93e-06	4.12e-05	CbGpPWpGaD
Methotrexate—ABCC1—Disease—CAV1—Alzheimer's disease	7.93e-06	4.11e-05	CbGpPWpGaD
Methotrexate—MTHFR—Disease—TGFB1—Alzheimer's disease	7.88e-06	4.09e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—TPI1—Alzheimer's disease	7.84e-06	4.07e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—CHAT—Alzheimer's disease	7.84e-06	4.07e-05	CbGpPWpGaD
Methotrexate—TYMS—Metabolism—NOS3—Alzheimer's disease	7.74e-06	4.02e-05	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—PPARGC1A—Alzheimer's disease	7.72e-06	4.01e-05	CbGpPWpGaD
Methotrexate—AOX1—Disease—TGFB1—Alzheimer's disease	7.7e-06	4e-05	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—HMOX1—Alzheimer's disease	7.69e-06	3.99e-05	CbGpPWpGaD
Methotrexate—SLC46A1—Metabolism—AKT1—Alzheimer's disease	7.6e-06	3.95e-05	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—LPL—Alzheimer's disease	7.59e-06	3.94e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—MAOB—Alzheimer's disease	7.52e-06	3.9e-05	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—CALM1—Alzheimer's disease	7.47e-06	3.88e-05	CbGpPWpGaD
Methotrexate—ABCC1—Disease—NOS2—Alzheimer's disease	7.45e-06	3.87e-05	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—PPARG—Alzheimer's disease	7.45e-06	3.87e-05	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—APOE—Alzheimer's disease	7.44e-06	3.87e-05	CbGpPWpGaD
Methotrexate—ALB—Hemostasis—IGF1—Alzheimer's disease	7.41e-06	3.85e-05	CbGpPWpGaD
Methotrexate—SLC16A1—Metabolism—PTGS2—Alzheimer's disease	7.39e-06	3.84e-05	CbGpPWpGaD
Methotrexate—ABCC1—Disease—NOTCH1—Alzheimer's disease	7.38e-06	3.83e-05	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—CAV1—Alzheimer's disease	7.38e-06	3.83e-05	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—INS—Alzheimer's disease	7.3e-06	3.79e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—GAPDH—Alzheimer's disease	7.24e-06	3.76e-05	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—MTHFR—Alzheimer's disease	7.2e-06	3.74e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	7.11e-06	3.69e-05	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism—NOS3—Alzheimer's disease	7.1e-06	3.69e-05	CbGpPWpGaD
Methotrexate—TYMS—Metabolism—PTGS2—Alzheimer's disease	7.08e-06	3.67e-05	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—LPL—Alzheimer's disease	7.03e-06	3.65e-05	CbGpPWpGaD
Methotrexate—DHFR—Disease—TGFB1—Alzheimer's disease	7e-06	3.64e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—A2M—Alzheimer's disease	6.99e-06	3.63e-05	CbGpPWpGaD
Methotrexate—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—Alzheimer's disease	6.99e-06	3.63e-05	CbGpPWpGaD
Methotrexate—PGD—Metabolism—AKT1—Alzheimer's disease	6.95e-06	3.61e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—ACHE—Alzheimer's disease	6.94e-06	3.6e-05	CbGpPWpGaD
Methotrexate—ABCC1—Disease—GSK3B—Alzheimer's disease	6.93e-06	3.6e-05	CbGpPWpGaD
Methotrexate—ABCC1—Disease—CREB1—Alzheimer's disease	6.87e-06	3.57e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—INPP5D—Alzheimer's disease	6.86e-06	3.56e-05	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—MTHFR—Alzheimer's disease	6.84e-06	3.55e-05	CbGpPWpGaD
Methotrexate—ABCC1—Disease—INS—Alzheimer's disease	6.83e-06	3.55e-05	CbGpPWpGaD
Methotrexate—ABCC4—Hemostasis—AKT1—Alzheimer's disease	6.83e-06	3.54e-05	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—CALM1—Alzheimer's disease	6.72e-06	3.49e-05	CbGpPWpGaD
Methotrexate—ALB—Hemostasis—NOS3—Alzheimer's disease	6.72e-06	3.49e-05	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—APOE—Alzheimer's disease	6.7e-06	3.48e-05	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—CAV1—Alzheimer's disease	6.64e-06	3.45e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—PTGS1—Alzheimer's disease	6.5e-06	3.38e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—ENO1—Alzheimer's disease	6.5e-06	3.38e-05	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism—PTGS2—Alzheimer's disease	6.49e-06	3.37e-05	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—PPARG—Alzheimer's disease	6.48e-06	3.37e-05	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—NOS3—Alzheimer's disease	6.4e-06	3.33e-05	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—CALM1—Alzheimer's disease	6.39e-06	3.32e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—CYP2D6—Alzheimer's disease	6.38e-06	3.31e-05	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—APOE—Alzheimer's disease	6.37e-06	3.31e-05	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—INS—Alzheimer's disease	6.36e-06	3.3e-05	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—MTHFR—Alzheimer's disease	6.33e-06	3.29e-05	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—CAV1—Alzheimer's disease	6.31e-06	3.27e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—ACHE—Alzheimer's disease	6.08e-06	3.16e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—BCHE—Alzheimer's disease	6.05e-06	3.14e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—INPP5D—Alzheimer's disease	6.01e-06	3.12e-05	CbGpPWpGaD
Methotrexate—ALB—Platelet activation, signaling and aggregation—AKT1—Alzheimer's disease	5.99e-06	3.11e-05	CbGpPWpGaD
Methotrexate—ABCC1—Disease—NOS3—Alzheimer's disease	5.99e-06	3.11e-05	CbGpPWpGaD
Methotrexate—MTHFR—Disease—IL6—Alzheimer's disease	5.94e-06	3.08e-05	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—CALM1—Alzheimer's disease	5.92e-06	3.07e-05	CbGpPWpGaD
Methotrexate—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—Alzheimer's disease	5.9e-06	3.06e-05	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—APOE—Alzheimer's disease	5.89e-06	3.06e-05	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—PTGS2—Alzheimer's disease	5.86e-06	3.04e-05	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—CAV1—Alzheimer's disease	5.84e-06	3.03e-05	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—PPARG—Alzheimer's disease	5.83e-06	3.03e-05	CbGpPWpGaD
Methotrexate—AOX1—Disease—IL6—Alzheimer's disease	5.8e-06	3.01e-05	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—INS—Alzheimer's disease	5.72e-06	2.97e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—PLCB1—Alzheimer's disease	5.7e-06	2.96e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—PTGS1—Alzheimer's disease	5.7e-06	2.96e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—ENO1—Alzheimer's disease	5.7e-06	2.96e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	5.6e-06	2.91e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—CYP2D6—Alzheimer's disease	5.59e-06	2.9e-05	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—NOS3—Alzheimer's disease	5.58e-06	2.9e-05	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—PPARG—Alzheimer's disease	5.54e-06	2.88e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—ABCA1—Alzheimer's disease	5.53e-06	2.87e-05	CbGpPWpGaD
Methotrexate—ABCC1—Disease—PTGS2—Alzheimer's disease	5.48e-06	2.85e-05	CbGpPWpGaD
Methotrexate—MTHFR—Disease—AKT1—Alzheimer's disease	5.48e-06	2.84e-05	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—INS—Alzheimer's disease	5.44e-06	2.82e-05	CbGpPWpGaD
Methotrexate—AOX1—Disease—AKT1—Alzheimer's disease	5.35e-06	2.78e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—BCHE—Alzheimer's disease	5.3e-06	2.75e-05	CbGpPWpGaD
Methotrexate—DHFR—Disease—IL6—Alzheimer's disease	5.28e-06	2.74e-05	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—PPARG—Alzheimer's disease	5.13e-06	2.67e-05	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—PTGS2—Alzheimer's disease	5.1e-06	2.65e-05	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—INS—Alzheimer's disease	5.04e-06	2.61e-05	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—NOS3—Alzheimer's disease	5.02e-06	2.61e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—PLCB1—Alzheimer's disease	5e-06	2.6e-05	CbGpPWpGaD
Methotrexate—DHFR—Disease—AKT1—Alzheimer's disease	4.87e-06	2.53e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—ABCA1—Alzheimer's disease	4.85e-06	2.52e-05	CbGpPWpGaD
Methotrexate—ALB—Hemostasis—VEGFA—Alzheimer's disease	4.84e-06	2.51e-05	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—NOS3—Alzheimer's disease	4.77e-06	2.48e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—PPARGC1A—Alzheimer's disease	4.77e-06	2.47e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—HMOX1—Alzheimer's disease	4.74e-06	2.46e-05	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—PTGS2—Alzheimer's disease	4.59e-06	2.38e-05	CbGpPWpGaD
Methotrexate—MTHFR—Metabolism—AKT1—Alzheimer's disease	4.59e-06	2.38e-05	CbGpPWpGaD
Methotrexate—AOX1—Metabolism—AKT1—Alzheimer's disease	4.48e-06	2.33e-05	CbGpPWpGaD
Methotrexate—ALB—Hemostasis—TGFB1—Alzheimer's disease	4.44e-06	2.31e-05	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—NOS3—Alzheimer's disease	4.42e-06	2.29e-05	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—PTGS2—Alzheimer's disease	4.36e-06	2.26e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—LPL—Alzheimer's disease	4.34e-06	2.25e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—PPARGC1A—Alzheimer's disease	4.18e-06	2.17e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—HMOX1—Alzheimer's disease	4.16e-06	2.16e-05	CbGpPWpGaD
Methotrexate—DHFR—Metabolism—AKT1—Alzheimer's disease	4.08e-06	2.12e-05	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—PTGS2—Alzheimer's disease	4.04e-06	2.1e-05	CbGpPWpGaD
Methotrexate—ABCC1—Disease—TGFB1—Alzheimer's disease	3.96e-06	2.06e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—MTHFR—Alzheimer's disease	3.91e-06	2.03e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—LPL—Alzheimer's disease	3.8e-06	1.97e-05	CbGpPWpGaD
Methotrexate—SLC16A1—Metabolism—AKT1—Alzheimer's disease	3.71e-06	1.93e-05	CbGpPWpGaD
Methotrexate—ALB—Hemostasis—TP53—Alzheimer's disease	3.66e-06	1.9e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—CALM1—Alzheimer's disease	3.65e-06	1.9e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—APOE—Alzheimer's disease	3.64e-06	1.89e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—CAV1—Alzheimer's disease	3.6e-06	1.87e-05	CbGpPWpGaD
Methotrexate—TYMS—Metabolism—AKT1—Alzheimer's disease	3.56e-06	1.85e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—MTHFR—Alzheimer's disease	3.42e-06	1.78e-05	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism—AKT1—Alzheimer's disease	3.26e-06	1.69e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—CALM1—Alzheimer's disease	3.2e-06	1.66e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—APOE—Alzheimer's disease	3.19e-06	1.65e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—PPARG—Alzheimer's disease	3.17e-06	1.64e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—CAV1—Alzheimer's disease	3.16e-06	1.64e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—INS—Alzheimer's disease	3.11e-06	1.61e-05	CbGpPWpGaD
Methotrexate—ALB—Hemostasis—AKT1—Alzheimer's disease	3.09e-06	1.6e-05	CbGpPWpGaD
Methotrexate—ABCC1—Disease—IL6—Alzheimer's disease	2.99e-06	1.55e-05	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—AKT1—Alzheimer's disease	2.94e-06	1.53e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—PPARG—Alzheimer's disease	2.78e-06	1.44e-05	CbGpPWpGaD
Methotrexate—ABCC1—Disease—AKT1—Alzheimer's disease	2.75e-06	1.43e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—NOS3—Alzheimer's disease	2.72e-06	1.41e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—INS—Alzheimer's disease	2.72e-06	1.41e-05	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—AKT1—Alzheimer's disease	2.56e-06	1.33e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—PTGS2—Alzheimer's disease	2.49e-06	1.29e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—NOS3—Alzheimer's disease	2.39e-06	1.24e-05	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—AKT1—Alzheimer's disease	2.31e-06	1.2e-05	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—AKT1—Alzheimer's disease	2.19e-06	1.14e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—PTGS2—Alzheimer's disease	2.18e-06	1.13e-05	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—AKT1—Alzheimer's disease	2.03e-06	1.05e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—AKT1—Alzheimer's disease	1.25e-06	6.5e-06	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—AKT1—Alzheimer's disease	1.1e-06	5.7e-06	CbGpPWpGaD
